nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Lamivudine—hepatitis B	0.18	0.735	CbGbCtD
Afatinib—ABCB1—Lamivudine—hepatitis B	0.0651	0.265	CbGbCtD
Afatinib—Disease progression—Telbivudine—hepatitis B	0.0308	0.0913	CcSEcCtD
Afatinib—ERBB2—Aciclovir—Entecavir—hepatitis B	0.0112	1	CbGdCrCtD
Afatinib—Rhinorrhoea—Telbivudine—hepatitis B	0.00831	0.0246	CcSEcCtD
Afatinib—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0061	0.0181	CcSEcCtD
Afatinib—Sepsis—Telbivudine—hepatitis B	0.00584	0.0173	CcSEcCtD
Afatinib—Renal impairment—Telbivudine—hepatitis B	0.00514	0.0152	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00512	0.0152	CcSEcCtD
Afatinib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00478	0.0141	CcSEcCtD
Afatinib—Rhinorrhoea—Lamivudine—hepatitis B	0.00468	0.0139	CcSEcCtD
Afatinib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00454	0.0134	CcSEcCtD
Afatinib—Renal failure—Entecavir—hepatitis B	0.00451	0.0133	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0044	0.013	CcSEcCtD
Afatinib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.0044	0.013	CcSEcCtD
Afatinib—Nasopharyngitis—Telbivudine—hepatitis B	0.00437	0.0129	CcSEcCtD
Afatinib—Hepatobiliary disease—Entecavir—hepatitis B	0.00434	0.0128	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00431	0.0128	CcSEcCtD
Afatinib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00423	0.0125	CcSEcCtD
Afatinib—BLK—blood—hepatitis B	0.00404	0.146	CbGeAlD
Afatinib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00397	0.0117	CcSEcCtD
Afatinib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00395	0.0117	CcSEcCtD
Afatinib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00394	0.0117	CcSEcCtD
Afatinib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00393	0.0116	CcSEcCtD
Afatinib—Renal failure—Telbivudine—hepatitis B	0.0037	0.011	CcSEcCtD
Afatinib—Alopecia—Entecavir—hepatitis B	0.00364	0.0108	CcSEcCtD
Afatinib—Mental disorder—Entecavir—hepatitis B	0.00361	0.0107	CcSEcCtD
Afatinib—Malnutrition—Entecavir—hepatitis B	0.00358	0.0106	CcSEcCtD
Afatinib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00356	0.0105	CcSEcCtD
Afatinib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0035	0.0103	CcSEcCtD
Afatinib—Mouth ulceration—Lamivudine—hepatitis B	0.00343	0.0102	CcSEcCtD
Afatinib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00338	0.01	CcSEcCtD
Afatinib—Connective tissue disorder—Telbivudine—hepatitis B	0.00332	0.00983	CcSEcCtD
Afatinib—Sepsis—Lamivudine—hepatitis B	0.00329	0.00975	CcSEcCtD
Afatinib—Cough—Adefovir Dipivoxil—hepatitis B	0.00305	0.00903	CcSEcCtD
Afatinib—Mediastinal disorder—Telbivudine—hepatitis B	0.00305	0.00902	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00303	0.00897	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00296	0.00875	CcSEcCtD
Afatinib—Malnutrition—Telbivudine—hepatitis B	0.00294	0.00871	CcSEcCtD
Afatinib—Infection—Entecavir—hepatitis B	0.00291	0.0086	CcSEcCtD
Afatinib—Renal impairment—Lamivudine—hepatitis B	0.00289	0.00857	CcSEcCtD
Afatinib—Dysgeusia—Telbivudine—hepatitis B	0.00288	0.00853	CcSEcCtD
Afatinib—Nervous system disorder—Entecavir—hepatitis B	0.00287	0.00849	CcSEcCtD
Afatinib—Back pain—Telbivudine—hepatitis B	0.00285	0.00843	CcSEcCtD
Afatinib—Skin disorder—Entecavir—hepatitis B	0.00284	0.00841	CcSEcCtD
Afatinib—Muscle spasms—Telbivudine—hepatitis B	0.00283	0.00838	CcSEcCtD
Afatinib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0028	0.00828	CcSEcCtD
Afatinib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00277	0.0082	CcSEcCtD
Afatinib—ERBB2—blood—hepatitis B	0.00277	0.1	CbGeAlD
Afatinib—Insomnia—Entecavir—hepatitis B	0.00264	0.00783	CcSEcCtD
Afatinib—Dyspepsia—Entecavir—hepatitis B	0.00257	0.00762	CcSEcCtD
Afatinib—Cough—Telbivudine—hepatitis B	0.00257	0.0076	CcSEcCtD
Afatinib—Dehydration—Lamivudine—hepatitis B	0.00256	0.00758	CcSEcCtD
Afatinib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00252	0.00747	CcSEcCtD
Afatinib—Fatigue—Entecavir—hepatitis B	0.00252	0.00746	CcSEcCtD
Afatinib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00251	0.00743	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00249	0.00737	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00248	0.00734	CcSEcCtD
Afatinib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00248	0.00734	CcSEcCtD
Afatinib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00246	0.00729	CcSEcCtD
Afatinib—Nasopharyngitis—Lamivudine—hepatitis B	0.00246	0.00729	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00243	0.00719	CcSEcCtD
Afatinib—PHKG2—liver—hepatitis B	0.00241	0.0873	CbGeAlD
Afatinib—Nervous system disorder—Telbivudine—hepatitis B	0.00236	0.00697	CcSEcCtD
Afatinib—Skin disorder—Telbivudine—hepatitis B	0.00233	0.00691	CcSEcCtD
Afatinib—Body temperature increased—Entecavir—hepatitis B	0.00231	0.00684	CcSEcCtD
Afatinib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00226	0.00668	CcSEcCtD
Afatinib—Insomnia—Telbivudine—hepatitis B	0.00217	0.00643	CcSEcCtD
Afatinib—ERBB2—liver—hepatitis B	0.00216	0.0785	CbGeAlD
Afatinib—Dyspepsia—Telbivudine—hepatitis B	0.00211	0.00626	CcSEcCtD
Afatinib—Asthenia—Entecavir—hepatitis B	0.0021	0.00621	CcSEcCtD
Afatinib—Renal failure—Lamivudine—hepatitis B	0.00209	0.00618	CcSEcCtD
Afatinib—DYRK1A—liver—hepatitis B	0.00208	0.0755	CbGeAlD
Afatinib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00207	0.00614	CcSEcCtD
Afatinib—Fatigue—Telbivudine—hepatitis B	0.00207	0.00613	CcSEcCtD
Afatinib—Stomatitis—Lamivudine—hepatitis B	0.00207	0.00612	CcSEcCtD
Afatinib—IRAK1—blood—hepatitis B	0.00207	0.0751	CbGeAlD
Afatinib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00205	0.00606	CcSEcCtD
Afatinib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00202	0.00597	CcSEcCtD
Afatinib—LCK—blood—hepatitis B	0.00202	0.0732	CbGeAlD
Afatinib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00201	0.00594	CcSEcCtD
Afatinib—Epistaxis—Lamivudine—hepatitis B	0.002	0.00593	CcSEcCtD
Afatinib—Diarrhoea—Entecavir—hepatitis B	0.002	0.00592	CcSEcCtD
Afatinib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00195	0.00578	CcSEcCtD
Afatinib—Dizziness—Entecavir—hepatitis B	0.00193	0.00572	CcSEcCtD
Afatinib—Body temperature increased—Telbivudine—hepatitis B	0.0019	0.00562	CcSEcCtD
Afatinib—Connective tissue disorder—Lamivudine—hepatitis B	0.00187	0.00554	CcSEcCtD
Afatinib—Vomiting—Entecavir—hepatitis B	0.00186	0.0055	CcSEcCtD
Afatinib—Rash—Entecavir—hepatitis B	0.00184	0.00546	CcSEcCtD
Afatinib—Dermatitis—Entecavir—hepatitis B	0.00184	0.00545	CcSEcCtD
Afatinib—EGFR—liver—hepatitis B	0.00183	0.0665	CbGeAlD
Afatinib—Headache—Entecavir—hepatitis B	0.00183	0.00542	CcSEcCtD
Afatinib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00181	0.00537	CcSEcCtD
Afatinib—Rash—Adefovir Dipivoxil—hepatitis B	0.0018	0.00532	CcSEcCtD
Afatinib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0018	0.00532	CcSEcCtD
Afatinib—Headache—Adefovir Dipivoxil—hepatitis B	0.00179	0.00529	CcSEcCtD
Afatinib—Nausea—Entecavir—hepatitis B	0.00174	0.00514	CcSEcCtD
Afatinib—Asthenia—Telbivudine—hepatitis B	0.00172	0.0051	CcSEcCtD
Afatinib—Mediastinal disorder—Lamivudine—hepatitis B	0.00172	0.00508	CcSEcCtD
Afatinib—Pruritus—Telbivudine—hepatitis B	0.0017	0.00503	CcSEcCtD
Afatinib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00169	0.00502	CcSEcCtD
Afatinib—Alopecia—Lamivudine—hepatitis B	0.00168	0.00498	CcSEcCtD
Afatinib—Malnutrition—Lamivudine—hepatitis B	0.00166	0.00491	CcSEcCtD
Afatinib—Diarrhoea—Telbivudine—hepatitis B	0.00164	0.00486	CcSEcCtD
Afatinib—Dysgeusia—Lamivudine—hepatitis B	0.00162	0.00481	CcSEcCtD
Afatinib—IRAK1—liver—hepatitis B	0.00162	0.0587	CbGeAlD
Afatinib—Back pain—Lamivudine—hepatitis B	0.0016	0.00475	CcSEcCtD
Afatinib—Muscle spasms—Lamivudine—hepatitis B	0.00159	0.00472	CcSEcCtD
Afatinib—Dizziness—Telbivudine—hepatitis B	0.00159	0.0047	CcSEcCtD
Afatinib—LCK—liver—hepatitis B	0.00158	0.0573	CbGeAlD
Afatinib—Vomiting—Telbivudine—hepatitis B	0.00153	0.00452	CcSEcCtD
Afatinib—Rash—Telbivudine—hepatitis B	0.00151	0.00448	CcSEcCtD
Afatinib—Dermatitis—Telbivudine—hepatitis B	0.00151	0.00448	CcSEcCtD
Afatinib—Headache—Telbivudine—hepatitis B	0.0015	0.00445	CcSEcCtD
Afatinib—Cough—Lamivudine—hepatitis B	0.00145	0.00428	CcSEcCtD
Afatinib—Nausea—Telbivudine—hepatitis B	0.00143	0.00422	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0014	0.00415	CcSEcCtD
Afatinib—Infection—Lamivudine—hepatitis B	0.00134	0.00398	CcSEcCtD
Afatinib—Nervous system disorder—Lamivudine—hepatitis B	0.00133	0.00393	CcSEcCtD
Afatinib—Skin disorder—Lamivudine—hepatitis B	0.00131	0.00389	CcSEcCtD
Afatinib—Insomnia—Lamivudine—hepatitis B	0.00122	0.00362	CcSEcCtD
Afatinib—Dyspnoea—Lamivudine—hepatitis B	0.00121	0.00357	CcSEcCtD
Afatinib—Dyspepsia—Lamivudine—hepatitis B	0.00119	0.00353	CcSEcCtD
Afatinib—Decreased appetite—Lamivudine—hepatitis B	0.00118	0.00348	CcSEcCtD
Afatinib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00117	0.00346	CcSEcCtD
Afatinib—Fatigue—Lamivudine—hepatitis B	0.00117	0.00345	CcSEcCtD
Afatinib—ABL1—blood—hepatitis B	0.00116	0.042	CbGeAlD
Afatinib—Constipation—Lamivudine—hepatitis B	0.00116	0.00343	CcSEcCtD
Afatinib—Body temperature increased—Lamivudine—hepatitis B	0.00107	0.00317	CcSEcCtD
Afatinib—ABCB1—blood plasma—hepatitis B	0.000984	0.0357	CbGeAlD
Afatinib—Vandetanib—ALB—hepatitis B	0.000977	0.513	CrCbGaD
Afatinib—Asthenia—Lamivudine—hepatitis B	0.000971	0.00287	CcSEcCtD
Afatinib—Pruritus—Lamivudine—hepatitis B	0.000958	0.00283	CcSEcCtD
Afatinib—Gefitinib—ALB—hepatitis B	0.000928	0.487	CrCbGaD
Afatinib—Diarrhoea—Lamivudine—hepatitis B	0.000926	0.00274	CcSEcCtD
Afatinib—ABL1—liver—hepatitis B	0.000906	0.0329	CbGeAlD
Afatinib—Dizziness—Lamivudine—hepatitis B	0.000895	0.00265	CcSEcCtD
Afatinib—Vomiting—Lamivudine—hepatitis B	0.000861	0.00255	CcSEcCtD
Afatinib—Rash—Lamivudine—hepatitis B	0.000854	0.00253	CcSEcCtD
Afatinib—Dermatitis—Lamivudine—hepatitis B	0.000853	0.00252	CcSEcCtD
Afatinib—Headache—Lamivudine—hepatitis B	0.000848	0.00251	CcSEcCtD
Afatinib—Nausea—Lamivudine—hepatitis B	0.000804	0.00238	CcSEcCtD
Afatinib—ABCG2—blood—hepatitis B	0.000731	0.0265	CbGeAlD
Afatinib—ABCG2—liver—hepatitis B	0.000571	0.0207	CbGeAlD
Afatinib—ABCB1—blood—hepatitis B	0.00036	0.0131	CbGeAlD
Afatinib—ABCB1—liver—hepatitis B	0.000282	0.0102	CbGeAlD
Afatinib—LCK—Immune System—IFNB1—hepatitis B	6.36e-05	0.000169	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—IL6—hepatitis B	6.29e-05	0.000167	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNA1—hepatitis B	6.21e-05	0.000165	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IFNG—hepatitis B	6.2e-05	0.000165	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCR5—hepatitis B	6.16e-05	0.000164	CbGpPWpGaD
Afatinib—IRAK1—Immune System—TLR4—hepatitis B	6.14e-05	0.000163	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-DRB1—hepatitis B	6.14e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	6.13e-05	0.000163	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IFNG—hepatitis B	6.11e-05	0.000162	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCR5—hepatitis B	6.07e-05	0.000161	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ALB—hepatitis B	6.04e-05	0.000161	CbGpPWpGaD
Afatinib—PHKG2—Disease—IL6—hepatitis B	6.03e-05	0.00016	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD14—hepatitis B	5.99e-05	0.000159	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNA2—hepatitis B	5.99e-05	0.000159	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL18—hepatitis B	5.99e-05	0.000159	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD4—hepatitis B	5.99e-05	0.000159	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD40LG—hepatitis B	5.96e-05	0.000159	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—IL2—hepatitis B	5.94e-05	0.000158	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	5.92e-05	0.000157	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	5.9e-05	0.000157	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD8A—hepatitis B	5.9e-05	0.000157	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD4—hepatitis B	5.9e-05	0.000157	CbGpPWpGaD
Afatinib—BLK—Immune System—IFNG—hepatitis B	5.87e-05	0.000156	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—CTNNB1—hepatitis B	5.85e-05	0.000156	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD4—hepatitis B	5.81e-05	0.000155	CbGpPWpGaD
Afatinib—LCK—Immune System—CD14—hepatitis B	5.78e-05	0.000154	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNA2—hepatitis B	5.78e-05	0.000154	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL10—hepatitis B	5.75e-05	0.000153	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CYP2A6—hepatitis B	5.71e-05	0.000152	CbGpPWpGaD
Afatinib—EGFR—Disease—GOT1—hepatitis B	5.7e-05	0.000152	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—NFKB1—hepatitis B	5.67e-05	0.000151	CbGpPWpGaD
Afatinib—BLK—Immune System—CD4—hepatitis B	5.67e-05	0.000151	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—IL6—hepatitis B	5.56e-05	0.000148	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—hepatitis B	5.53e-05	0.000147	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL2—hepatitis B	5.51e-05	0.000147	CbGpPWpGaD
Afatinib—LCK—Disease—GOT1—hepatitis B	5.49e-05	0.000146	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—IL6—hepatitis B	5.48e-05	0.000146	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—hepatitis B	5.44e-05	0.000145	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL2—hepatitis B	5.43e-05	0.000144	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	5.39e-05	0.000144	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CTNNB1—hepatitis B	5.32e-05	0.000141	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AKR1B1—hepatitis B	5.31e-05	0.000141	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—F2—hepatitis B	5.29e-05	0.000141	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	5.27e-05	0.00014	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	5.26e-05	0.00014	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-A—hepatitis B	5.26e-05	0.00014	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CTNNB1—hepatitis B	5.24e-05	0.000139	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	5.23e-05	0.000139	CbGpPWpGaD
Afatinib—BLK—Immune System—IL2—hepatitis B	5.22e-05	0.000139	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—F2—hepatitis B	5.21e-05	0.000139	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CDKN1A—hepatitis B	5.19e-05	0.000138	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PTEN—hepatitis B	5.18e-05	0.000138	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CTNNB1—hepatitis B	5.16e-05	0.000137	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT2—hepatitis B	5.16e-05	0.000137	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NFKB1—hepatitis B	5.16e-05	0.000137	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CDKN1A—hepatitis B	5.12e-05	0.000136	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL18—hepatitis B	5.12e-05	0.000136	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PTEN—hepatitis B	5.1e-05	0.000136	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD40LG—hepatitis B	5.1e-05	0.000136	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT2—hepatitis B	5.09e-05	0.000136	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NFKB1—hepatitis B	5.08e-05	0.000135	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	5.06e-05	0.000135	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CDKN1A—hepatitis B	5.05e-05	0.000134	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCR5—hepatitis B	5.04e-05	0.000134	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD8A—hepatitis B	5.04e-05	0.000134	CbGpPWpGaD
Afatinib—BLK—Immune System—CTNNB1—hepatitis B	5.04e-05	0.000134	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—PTEN—hepatitis B	5.03e-05	0.000134	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NFKB1—hepatitis B	5.01e-05	0.000133	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—CTNNB1—hepatitis B	5e-05	0.000133	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—IL6—hepatitis B	4.99e-05	0.000133	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—hepatitis B	4.97e-05	0.000132	CbGpPWpGaD
Afatinib—LCK—Immune System—IL18—hepatitis B	4.93e-05	0.000131	CbGpPWpGaD
Afatinib—BLK—Immune System—CDKN1A—hepatitis B	4.92e-05	0.000131	CbGpPWpGaD
Afatinib—LCK—Immune System—CD40LG—hepatitis B	4.91e-05	0.000131	CbGpPWpGaD
Afatinib—BLK—Immune System—PTEN—hepatitis B	4.91e-05	0.000131	CbGpPWpGaD
Afatinib—ERBB2—Disease—CTNNB1—hepatitis B	4.91e-05	0.000131	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL2—hepatitis B	4.89e-05	0.00013	CbGpPWpGaD
Afatinib—BLK—Immune System—NFKB1—hepatitis B	4.89e-05	0.00013	CbGpPWpGaD
Afatinib—LCK—Immune System—CD8A—hepatitis B	4.86e-05	0.000129	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—NFKB1—hepatitis B	4.85e-05	0.000129	CbGpPWpGaD
Afatinib—ERBB4—Disease—CTNNB1—hepatitis B	4.84e-05	0.000129	CbGpPWpGaD
Afatinib—ABL1—Immune System—TLR4—hepatitis B	4.81e-05	0.000128	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DRB1—hepatitis B	4.8e-05	0.000128	CbGpPWpGaD
Afatinib—ERBB2—Disease—CDKN1A—hepatitis B	4.8e-05	0.000128	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—hepatitis B	4.79e-05	0.000127	CbGpPWpGaD
Afatinib—ERBB2—Disease—PTEN—hepatitis B	4.78e-05	0.000127	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—hepatitis B	4.77e-05	0.000127	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TGFB1—hepatitis B	4.73e-05	0.000126	CbGpPWpGaD
Afatinib—ERBB4—Disease—CDKN1A—hepatitis B	4.72e-05	0.000126	CbGpPWpGaD
Afatinib—ERBB4—Disease—PTEN—hepatitis B	4.71e-05	0.000125	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—hepatitis B	4.71e-05	0.000125	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TGFB1—hepatitis B	4.64e-05	0.000123	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—hepatitis B	4.62e-05	0.000123	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—hepatitis B	4.6e-05	0.000122	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—hepatitis B	4.54e-05	0.000121	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-A—hepatitis B	4.49e-05	0.000119	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IFNG—hepatitis B	4.48e-05	0.000119	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT1—hepatitis B	4.46e-05	0.000119	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GGT1—hepatitis B	4.46e-05	0.000119	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCR5—hepatitis B	4.46e-05	0.000119	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CTNNB1—hepatitis B	4.41e-05	0.000117	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—hepatitis B	4.41e-05	0.000117	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	4.36e-05	0.000116	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—hepatitis B	4.33e-05	0.000115	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-A—hepatitis B	4.33e-05	0.000115	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—F2—hepatitis B	4.33e-05	0.000115	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CDKN1A—hepatitis B	4.31e-05	0.000115	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PTEN—hepatitis B	4.3e-05	0.000114	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NFKB1—hepatitis B	4.28e-05	0.000114	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—hepatitis B	4.26e-05	0.000113	CbGpPWpGaD
Afatinib—EGFR—Disease—CCR5—hepatitis B	4.26e-05	0.000113	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CTNNB1—hepatitis B	4.25e-05	0.000113	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CDKN1A—hepatitis B	4.15e-05	0.000111	CbGpPWpGaD
Afatinib—EGFR—Disease—HLA-A—hepatitis B	4.15e-05	0.00011	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PTEN—hepatitis B	4.15e-05	0.00011	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CDKN1A—hepatitis B	4.14e-05	0.00011	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PTEN—hepatitis B	4.13e-05	0.00011	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NFKB1—hepatitis B	4.13e-05	0.00011	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NFKB1—hepatitis B	4.11e-05	0.000109	CbGpPWpGaD
Afatinib—EGFR—Immune System—TLR4—hepatitis B	4.11e-05	0.000109	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—hepatitis B	4.1e-05	0.000109	CbGpPWpGaD
Afatinib—LCK—Disease—CCR5—hepatitis B	4.1e-05	0.000109	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	4.07e-05	0.000108	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TGFB1—hepatitis B	4.04e-05	0.000107	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—hepatitis B	4.02e-05	0.000107	CbGpPWpGaD
Afatinib—LCK—Disease—HLA-A—hepatitis B	4e-05	0.000106	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CDKN1A—hepatitis B	3.99e-05	0.000106	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—hepatitis B	3.98e-05	0.000106	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PTEN—hepatitis B	3.98e-05	0.000106	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFB1—hepatitis B	3.97e-05	0.000106	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NFKB1—hepatitis B	3.96e-05	0.000105	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR4—hepatitis B	3.96e-05	0.000105	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—hepatitis B	3.95e-05	0.000105	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFB1—hepatitis B	3.91e-05	0.000104	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CTNNB1—hepatitis B	3.84e-05	0.000102	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL10—hepatitis B	3.84e-05	0.000102	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—F2—hepatitis B	3.82e-05	0.000102	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TGFB1—hepatitis B	3.82e-05	0.000102	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TP53—hepatitis B	3.82e-05	0.000102	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—hepatitis B	3.77e-05	0.0001	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CDKN1A—hepatitis B	3.76e-05	9.99e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PTEN—hepatitis B	3.75e-05	9.97e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NFKB1—hepatitis B	3.73e-05	9.92e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL10—hepatitis B	3.7e-05	9.85e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—hepatitis B	3.61e-05	9.6e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.59e-05	9.55e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—hepatitis B	3.56e-05	9.47e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—hepatitis B	3.56e-05	9.47e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—hepatitis B	3.51e-05	9.33e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—hepatitis B	3.51e-05	9.33e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—hepatitis B	3.48e-05	9.25e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CTNNB1—hepatitis B	3.44e-05	9.15e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—hepatitis B	3.39e-05	9.01e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CTNNB1—hepatitis B	3.39e-05	9.01e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CDKN1A—hepatitis B	3.36e-05	8.93e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PTEN—hepatitis B	3.35e-05	8.91e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NFKB1—hepatitis B	3.33e-05	8.87e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CDKN1A—hepatitis B	3.31e-05	8.8e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PTEN—hepatitis B	3.3e-05	8.78e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NFKB1—hepatitis B	3.28e-05	8.74e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—hepatitis B	3.24e-05	8.61e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—hepatitis B	3.19e-05	8.48e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—hepatitis B	3.14e-05	8.37e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TP53—hepatitis B	3.14e-05	8.36e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—hepatitis B	3.12e-05	8.29e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP2A6—hepatitis B	3.09e-05	8.21e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—hepatitis B	3.07e-05	8.16e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—hepatitis B	3.04e-05	8.09e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CTNNB1—hepatitis B	3.01e-05	8e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—hepatitis B	3e-05	7.97e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—hepatitis B	2.99e-05	7.95e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR5—hepatitis B	2.98e-05	7.93e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—hepatitis B	2.94e-05	7.83e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—CDKN1A—hepatitis B	2.94e-05	7.82e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—PTEN—hepatitis B	2.93e-05	7.8e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—NFKB1—hepatitis B	2.92e-05	7.76e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—hepatitis B	2.91e-05	7.75e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—hepatitis B	2.89e-05	7.7e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—hepatitis B	2.89e-05	7.68e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR5—hepatitis B	2.87e-05	7.64e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT2—hepatitis B	2.79e-05	7.42e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—hepatitis B	2.79e-05	7.42e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—hepatitis B	2.78e-05	7.39e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.74e-05	7.28e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—hepatitis B	2.74e-05	7.28e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—hepatitis B	2.69e-05	7.15e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—hepatitis B	2.67e-05	7.11e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—hepatitis B	2.66e-05	7.08e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—hepatitis B	2.59e-05	6.89e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—hepatitis B	2.58e-05	6.85e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—hepatitis B	2.57e-05	6.85e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CTNNB1—hepatitis B	2.57e-05	6.84e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—hepatitis B	2.57e-05	6.83e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—F2—hepatitis B	2.56e-05	6.8e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CDKN1A—hepatitis B	2.51e-05	6.68e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—PTEN—hepatitis B	2.51e-05	6.66e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—NFKB1—hepatitis B	2.49e-05	6.63e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CTNNB1—hepatitis B	2.49e-05	6.61e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CTNNB1—hepatitis B	2.48e-05	6.59e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—F2—hepatitis B	2.46e-05	6.55e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CDKN1A—hepatitis B	2.43e-05	6.46e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTEN—hepatitis B	2.42e-05	6.44e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CDKN1A—hepatitis B	2.42e-05	6.44e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—PTEN—hepatitis B	2.41e-05	6.42e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NFKB1—hepatitis B	2.41e-05	6.41e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT1—hepatitis B	2.41e-05	6.41e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT1—hepatitis B	2.41e-05	6.41e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—NFKB1—hepatitis B	2.4e-05	6.39e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CTNNB1—hepatitis B	2.37e-05	6.31e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—hepatitis B	2.37e-05	6.31e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—hepatitis B	2.34e-05	6.23e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CDKN1A—hepatitis B	2.32e-05	6.17e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTEN—hepatitis B	2.31e-05	6.15e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CTNNB1—hepatitis B	2.29e-05	6.08e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TP53—hepatitis B	2.29e-05	6.08e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TP53—hepatitis B	2.25e-05	5.99e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CDKN1A—hepatitis B	2.23e-05	5.94e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTEN—hepatitis B	2.23e-05	5.93e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—hepatitis B	2.09e-05	5.57e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—hepatitis B	2.06e-05	5.48e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—hepatitis B	2.01e-05	5.34e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—hepatitis B	1.92e-05	5.1e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—hepatitis B	1.85e-05	4.92e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—hepatitis B	1.83e-05	4.87e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTEN—hepatitis B	1.81e-05	4.81e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—hepatitis B	1.72e-05	4.58e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—hepatitis B	1.71e-05	4.56e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CTNNB1—hepatitis B	1.66e-05	4.42e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—hepatitis B	1.66e-05	4.41e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TP53—hepatitis B	1.65e-05	4.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CDKN1A—hepatitis B	1.62e-05	4.32e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTEN—hepatitis B	1.62e-05	4.31e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NFKB1—hepatitis B	1.61e-05	4.29e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CTNNB1—hepatitis B	1.6e-05	4.26e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—hepatitis B	1.57e-05	4.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CDKN1A—hepatitis B	1.56e-05	4.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTEN—hepatitis B	1.56e-05	4.15e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NFKB1—hepatitis B	1.55e-05	4.13e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—hepatitis B	1.51e-05	4.03e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—hepatitis B	1.51e-05	4.01e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—hepatitis B	1.45e-05	3.84e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—hepatitis B	1.39e-05	3.7e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—hepatitis B	1.34e-05	3.57e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—hepatitis B	1.29e-05	3.44e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—hepatitis B	1.28e-05	3.41e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TP53—hepatitis B	1.11e-05	2.94e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TP53—hepatitis B	1.07e-05	2.83e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—hepatitis B	1.01e-05	2.69e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTEN—hepatitis B	9.78e-06	2.6e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—hepatitis B	9.75e-06	2.59e-05	CbGpPWpGaD
